Arbutus Biopharma
ABUS
#7051
Rank
C$0.88 B
Marketcap
C$5.77
Share price
-1.23%
Change (1 day)
-5.14%
Change (1 year)

EPS for Arbutus Biopharma (ABUS)

EPS in 2026 (TTM): C$1.14

According to Arbutus Biopharma 's latest financial reports the company's current EPS (TTM) is C$1.18. In 2025 the company made an earnings per share (EPS) of C-$0.24 an increase over its 2024 EPS that were of C-$0.54.

EPS history for Arbutus Biopharma from 1998 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$1.14-567.09%
2025C-$0.24-55.26%
2024C-$0.54-13.64%
2023C-$0.63-4.35%
2022C-$0.66-44.58%
2021C-$1.19-17%
2020C-$1.43-65.4%
2019C-$4.14138.84%
2018C-$1.74-22.44%
2017C-$2.24-78.45%
2016C-$10.38424.64%
2015C-$1.98-20.19%
2014C-$2.4887.96%
2013C-$1.32-142.59%
2012C$3.10-342.7%
2011C-$1.28-25.82%
2010C-$1.7247.8%
2009C-$1.16-43.55%
2008C-$2.06158.91%
2007C-$0.80-111.88%
2006C$6.71-552.53%
2005C-$1.48-71.77%
2004C-$5.25-14.48%
2003C-$6.14-8.95%
2002C-$6.7470.07%
2001C-$3.9648.01%
2000C-$2.68-38.54%
1999C-$4.36-24.6%
1998C-$5.78

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Nymox Pharmaceutical
NYMX
C-$0.08605-107.32% Bahamas
NRC Health
NRC
C$0.42-64.63%๐Ÿ‡บ๐Ÿ‡ธ USA